The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, PhD…
The Neurology Minute podcast is an incredible resource for anyone interested in neurology or seeking to expand their knowledge on the subject. Hosted by Dr. Stacey Clardy, the show excels at taking complex subjects and breaking them down in a way that is understandable to the average person. With episodes lasting just a minute or two, it's an easy listen that can truly change the way one speaks to a patient or even make a diagnosis.
One of the best aspects of The Neurology Minute podcast is its brevity combined with its informative and targeted content backed up by evidence-based science. Each episode provides concise information that is relevant and practical. The guests interviewed on this show are experts in their field, and their insights can have a direct impact on the care of patients. The interviews are thought-provoking and often provide unique perspectives not commonly found elsewhere.
Despite its many strengths, one possible drawback of The Neurology Minute podcast is its short format. While it is great for those who prefer quick learning bites or have limited time available, it may not delve as deeply into certain topics as some listeners would like. However, given that each episode lasts only a minute or two, it still manages to cover a surprising amount of information.
In conclusion, The Neurology Minute podcast is a must-listen for anyone interested in neurology or looking to enhance their medical knowledge. It offers concise yet impactful episodes that provide valuable insights from experts in the field. Whether you're a medical student considering neurology as a specialty or simply looking to broaden your understanding of neurological conditions, this podcast delivers high-quality content in bite-sized portions. Don't miss out on this opportunity to learn from some of the best minds in neurology!
Dr. Greg Cooper and Dr. Claudia Suemoto discuss the association between consumption of low- and no-calorie sweeteners and cognitive decline. Show citations: Gonçalves NG, Martinez-Steele E, Lotufo PA, et al. Association Between Consumption of Low- and No-Calorie Artificial Sweeteners and Cognitive Decline: An 8-Year Prospective Study. Neurology. 2025;105(7):e214023. doi:10.1212/WNL.0000000000214023
Dr. Paul Crane discusses Oropouche virus and its neurologic complications.
In the second part of this two-part series, Dr. Kaitlyn Palmer explains how these biomarkers change our approach to diagnosing multiple sclerosis. Show reference: Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Montalban, Xavier, et al. The Lancet Neurology, Volume 24, Issue 10, 850 - 865
In part one of this two-part series, Dr. Kaitlyn Palmer discusses two new MRI biomarkers to increase diagnostic specificity for multiple sclerosis. Show reference: Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Montalban, Xavier, et al. The Lancet Neurology, Volume 24, Issue 10, 850 - 865
Dr. Katie Krulisky and Dr. Rosemary Dray-Spira discuss the trends in prenatal exposure to antiseizure medications over the past decade. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213933 Citation: Pouneh S, Jérôme D, Sara M, et al. Trends in Prenatal Exposure to Antiseizure Medications Over the Past Decade: A Nationwide Study. Neurology. 2025;105(4): e213933.
Dr. Greg Cooper and Dr. Jonathan Graff-Redford discuss the key takeaways from the recent Alzheimer's Association International Conference (AAIC).
Dr. Margarita Fedorova discusses whether living near a golf course impacts the risk of Parkinson disease. Show reference: Krzyzanowski B, Mullan AF, Dorsey ER, et al. Proximity to Golf Courses and Risk of Parkinson Disease. JAMA Netw Open. 2025;8(5):e259198. doi:10.1001/jamanetworkopen.2025.9198
In the second episode of this two-part series, Dr. Justin Abbatemarco and Dr. Jennifer E. Fugate discuss patient outcomes and how to manage these individuals both in the hospital and outside the hospital. Show reference: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00232-7/abstract
In the first episode of this two-part series, Dr. Justin Abbatemarco and Dr. Jennifer E. Fugate discuss posterior reversible encephalopathy syndrome (PRES), highlighting both typical and atypical MRI findings. Show reference: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00232-7/abstract
Dr. Gregg Day and Drs. Laura Baker and Melissa Yu discuss interventions that enhance or safeguard cognitive function in older adults at risk of cognitive decline and dementia. Show reference: https://jamanetwork.com/journals/jama/article-abstract/2837046
In the second part of this two-part series, Casey Kozak concludes the discussion about the TOAST criteria for classifying acute ischemic stroke.
In the first part of this two-part series, Casey Kozak discusses the TOAST criteria for classifying acute ischemic stroke. In this episode, she covers large artery atherosclerosis and small vessel disease.
In the final episode of this five-part series, Dr. Paul Crane concludes the measles series by discussing testing and prevention.
In the fourth episode of this five-part series, Dr. Paul Crane discusses subacute sclerosing panencephalitis, a serious complication of measles.
Dr. Jessica Ailani and Dr. Kathleen Digre discuss three key updates in the understanding and management of idiopathic intracranial hypertension. Show references: https://jamanetwork.com/journals/jamaneurology/article-abstract/2836065 https://www.neurology.org/doi/10.1212/WNL.0000000000009312
Dr. Andy Southerland and Dr. Amrou Sarraj examine whether general anesthesia (GA) compared with non-GA was associated with better functional outcomes in the SELECT2 trial. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213819
In the October episode of the President's Spotlight, Dr. Jason Crowell talks with Dr. Natalia Rost about the crucial role research plays in neurology for clinicians and scientists. Show reference: https://www.aan.com/about-the-aan/presidents-spotlight
In this episode, Dr. Andy Southerland discusses the Capitol Hill Report from October 6th, covering the government shutdown and its potential impact on you and your patients. Stay updated with what's happening on the hill by visiting aan.com/chr. Take a minute to email your members of Congress and ensure your voice is heard!
In the second episode of this two-part series, Dr. Kiran Thakur and Dr. Ava Easton discuss how to get involved in advocacy efforts and policy development related to encephalitis. Show reference: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00057-6/fulltext
In part one of this two-part series, Dr. Kiran Thakur and Dr. Ava Easton discuss the World Health Organization's technical brief on encephalitis. Show reference: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00057-6/fulltext
In the third episode of this five-part series, Dr. Paul Crane discusses measles inclusion body encephalitis.
In the third episode of this five-part series, Dr. Paul Crane discusses measles inclusion body encephalitis.
In the second part of this five-part series, Dr. Paul Crane discusses the early neurologic complications associated with measles.
In the first part of this five-part series, Dr. Paul Crane discusses the reemergence of measles and outlines steps to take if you suspect someone may have measles.
In this episode, Dr. Andy Southerland discusses the Capitol Hill Report from September 8, providing important updates around BrainPAC. Stay updated with what's happening on the hill by visiting aan.com/chr. Learn how you can get involved with AAN advocacy.
Dr. Deanna Saylor and Dr. Senjuti Saha discuss colonialism in global health and the importance of pathogen genomics. Show reference: https://www.thelancet.com/journals/landig/article/PIIS2589-7500(24)00091-8/fulltext
In the final episode of this two-part series, Dr. Justin Abbatemarco discusses long-term maintenance therapy options. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200504
In part one of this two-part series, Dr. Justin Abbatemarco discusses what we know and don't know surrounding MOG antibody–associated diseases (MOGADs). Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200504
In the final part of this three-part series, Dr. Justin Abbatemarco and Drs. John Chen and Smathorn Thakolwiboon discuss how to approach discontinuation of immunotherapy in clinical practice. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213903
In part two of this three-part series, Dr. Justin Abbatemarco and Drs. John Chen and Smathorn Thakolwiboon discuss a long-term maintenance approach for MOGAD. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213903
In part two of this two-part series, Dr. Robert Holloway and Dr. Carolyn Rennels discuss the future of addressing intolerable suffering in practice and explore the opportunities for MAID. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200478
In part one of this two-part series, Dr. Robert Holloway and Dr. Carolyn Rennels discuss the main takeaway points from the paper. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200478
Dr. Justin Abbatemarco and Dr. Aaron Zelikovich discuss the safety and efficacy of satralizumab and its role in the current treatment landscape for myasthenia gravis. Show reference: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00514-3/fulltext
Dr. Bradley Ong discusses the efficacy and safety of fremanezumab in adults with migraine and comorbid major depressive disorder. Show reference: https://jamanetwork.com/journals/jamaneurology/fullarticle/2833452
In part two of this two-part series, Dr. Stacey Clardy and Dr. Walter Koroshetz discuss ways to empower professionals in the fields of neurology and research.
In the first part of this two-part series, Dr. Stacey Clardy and Dr. Walter Koroshetz discuss strategies for advancing the fields of neurology and neuroscience research.
Dr. Bakhtawar Ahmad discuss Ellen Grass the founder of the Grass Instruments Company, which played a vital role in the technological development of EEG in this women history minute.
Dr. Paige Kalika discusses the importance of embracing neurodiversity in medicine. Show reference: https://jamanetwork.com/journals/jama/article-abstract/2830611
Dr. Bradley Ong discusses a newly FDA-approved nasal powder formulation for treating debilitating migraine attacks.
In part two of this two-part series, Dr. Stacey Clardy and Dr. Andrew Mammen discuss what's new in the diagnosis and treatment of dermatomyositis.
In the first part of this two-part series, Dr. Stacey Clardy and Dr. Andrew Mammen discuss the advancements made over the past decade regarding HMGCR antibody-associated myositis and how to treat it.
In the September episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost highlight this year's AAN Brain Health Summit and discuss the events taking place. Show reference: https://www.aan.com/about-the-aan/presidents-spotlight https://www.aan.com/tools-resources/brain-health/brain-health-summit
In the fourth episode of this series, Dr. Andy Southerland discusses the Capitol Hill Report from August 11th, where AAN members met with their local state representatives to discuss making telehealth flexibilities permanent and reforming prior authorization processes. Stay updated with what's happening on the hill by visiting aan.com/chr. Learn how you can get involved with AAN advocacy.
In the final part of this series, Dr. Jeff Ratliff and Dr. Valtteri Kaasinen discuss how to speak with patients and families when having a conversation about an initial diagnosis of Parkinson disease. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213499
Dr. Alex Menze and Dr. Christopher J. Klein discuss whether GLP-1RA usage is linked to radiculoplexus neuropathy and common fibular neuropathy. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213916
In part one of this series, Dr. Jeff Ratliff and Dr. Valtteri Kaasinen discuss what this study teaches us about the diagnosis of Parkinson disease once it is given to patients who are subsequently followed over time. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213499
In the final episode of this foundational neurology series, Casey Kozak discusses serotonin syndrome.
In part four of this foundational neurology series, Casey Kozak explores neuroleptic malignant syndrome and highlights key similarities and differences with malignant hyperthermia.
In part three of this foundational neurology series, Casey Kozak discusses malignant hyperthermia caused by inhaled anesthetics and depolarizing neuromuscular blockers.
Dr. Trey Bateman and Dr. David T. Jones discuss how the StateViewer system leverages FDG-PET imaging and machine learning to improve diagnostic accuracy and clinical decision-making for Alzheimer disease and related disorders. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213831
Dr. Dan Ackerman talks with Dr. Urs Fischer about the optimal timing of anticoagulation after ischemic stroke in patients with atrial fibrillation. show reference: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00439-8/fulltext
© 2020-2025 Ivy Podcast Discovery LLC
